PortfoliosLab logoPortfoliosLab logo
NBIX vs. VTEB
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NBIX vs. VTEB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neurocrine Biosciences, Inc. (NBIX) and Vanguard Tax-Exempt Bond ETF (VTEB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NBIX achieves a 12.47% return, which is significantly higher than VTEB's 1.54% return. Over the past 10 years, NBIX has outperformed VTEB with an annualized return of 13.68%, while VTEB has yielded a comparatively lower 2.02% annualized return.


NBIX

1D
-0.16%
1M
0.69%
YTD
12.47%
6M
3.54%
1Y
28.23%
3Y*
17.79%
5Y*
10.10%
10Y*
13.68%

VTEB

1D
0.10%
1M
1.32%
YTD
1.54%
6M
1.95%
1Y
6.68%
3Y*
3.38%
5Y*
0.88%
10Y*
2.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NBIX vs. VTEB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NBIX
Neurocrine Biosciences, Inc.
12.47%3.90%3.60%10.31%40.24%-11.14%-10.83%50.53%-7.96%100.49%
VTEB
Vanguard Tax-Exempt Bond ETF
1.54%3.72%1.31%6.15%-7.99%1.14%5.19%7.35%1.04%4.87%

Correlation

The correlation between NBIX and VTEB is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Aug 25, 2015

-0.00

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NBIX vs. VTEB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIX
NBIX Risk / Return Rank: 6767
Overall Rank
NBIX Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
NBIX Sortino Ratio Rank: 6565
Sortino Ratio Rank
NBIX Omega Ratio Rank: 6666
Omega Ratio Rank
NBIX Calmar Ratio Rank: 6868
Calmar Ratio Rank
NBIX Martin Ratio Rank: 6868
Martin Ratio Rank

VTEB
VTEB Risk / Return Rank: 7676
Overall Rank
VTEB Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
VTEB Sortino Ratio Rank: 9090
Sortino Ratio Rank
VTEB Omega Ratio Rank: 9292
Omega Ratio Rank
VTEB Calmar Ratio Rank: 5555
Calmar Ratio Rank
VTEB Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBIX vs. VTEB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Vanguard Tax-Exempt Bond ETF (VTEB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NBIXVTEBDifference
Sharpe ratioReturn per unit of total volatility

-1.61

Sortino ratioReturn per unit of downside risk

-2.32

Omega ratioGain probability vs. loss probability

1.19

1.55

-0.36

Calmar ratioReturn relative to maximum drawdown

1.36

2.48

-1.12

Martin ratioReturn relative to average drawdown

2.98

8.75

-5.77

NBIX vs. VTEB - Sharpe Ratio Comparison

The current NBIX Sharpe Ratio is 0.90, which is lower than the VTEB Sharpe Ratio of 2.52. The chart below compares the historical Sharpe Ratios of NBIX and VTEB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NBIX vs. VTEB - Drawdown Comparison

The maximum NBIX drawdown since its inception was -97.21%, which is greater than VTEB's maximum drawdown of -17.00%. Use the drawdown chart below to compare losses from any high point for NBIX and VTEB.


Loading charts...

Drawdown Indicators


NBIXVTEBDifference

Max Drawdown

Largest peak-to-trough decline

-97.21%

-17.00%

-80.21%

Max Drawdown (1Y)

Largest decline over 1 year

-20.90%

-2.71%

-18.19%

Max Drawdown (3Y)

Largest decline over 3 years

-42.89%

-5.53%

-37.36%

Max Drawdown (5Y)

Largest decline over 5 years

-42.89%

-12.64%

-30.25%

Max Drawdown (10Y)

Largest decline over 10 years

-46.39%

-17.00%

-29.39%

Current Drawdown

Current decline from peak

-4.68%

-0.44%

-4.24%

Average Drawdown

Average peak-to-trough decline

-43.83%

-2.32%

-41.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.50%

0.77%

+8.73%

Volatility

NBIX vs. VTEB - Volatility Comparison

Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 9.52% compared to Vanguard Tax-Exempt Bond ETF (VTEB) at 0.92%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than VTEB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NBIXVTEBDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.52%

0.92%

+8.60%

Volatility (6M)

Calculated over the trailing 6-month period

23.90%

2.04%

+21.86%

Volatility (1Y)

Calculated over the trailing 1-year period

31.43%

2.67%

+28.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.73%

3.90%

+28.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.14%

5.26%

+33.88%

Dividends

NBIX vs. VTEB - Dividend Comparison

NBIX has not paid dividends to shareholders, while VTEB's dividend yield for the trailing twelve months is around 3.35%.


PositionTTM20252024202320222021202020192018201720162015
NBIX
Neurocrine Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VTEB
Vanguard Tax-Exempt Bond ETF
3.35%3.29%3.14%2.79%2.09%1.64%1.99%2.30%2.25%1.96%1.66%0.58%

Frequently Asked Questions


NBIX and VTEB have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NBIX has higher volatility (9.52%) compared to VTEB (0.92%). In terms of maximum drawdown, NBIX dropped -97.21% vs VTEB's -17.00%.

VTEB currently has the higher Sharpe Ratio (2.52 vs 0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NBIX and VTEB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer